SGMO: sangamo.com Company Total Sales

sangamo.com - graphic logo of issuer SGMO

Fundamental patents on "zinc fingers" create a powerful defensive barrier, and the current sales volume of Sangamo Therapeutics (SGMO) confirms this status: the 0.04 mark serves as a relevant indicator. Business resilience relies on a diversified network of rare biomaterial suppliers. This stability is complemented by a neutral geopolitical climate within the legal frameworks of the US and UK, which precludes the impact of trade sanctions.

Sangamo Therapeutics, Inc. (SGMO) - Revenue and Sales Volume from 07/04/2022 to 05/09/2026

Comprehensive metric breakdowns and analytics for Sangamo Therapeutics Inc. (SGMO)

Comprehensive company analysis:Sangamo Therapeutics (SGMO)
Flagship merchandise of Sangamo Therapeutics, Inc.

Sangamo Therapeutics (SGMO) demonstrates sustainable growth through the creation of unique therapeutic solutions. The company's current sales figures capture the actual volume of products sold, excluding speculative fluctuations in market value. The smoothed price action on this chart reflects the stability of commercial flows over the long term. The independence of the biotechnological cycle from macroeconomics ensures a constant inflow of capital. Such a fundamental base minimizes volatility and confirms the defensive qualities of the asset.

Key competitors

Tempus AI, Inc. (TEM) - Company Gross Revenue|Company Sales QGEN (Qiagen NV)|Revenue and Sales Volume Ionis Pharmaceuticals, Inc. (IONS)|Revenue and Sales Volume RGEN (Repligen Inc.)|Avidity Corp (RNA) - Company Total Revenue|CRSP - Company Revenue|Company Gross Revenue genedx.com WGS|Ultragenyx Pharmaceutical (RARE) - Company Revenue|Company Total Revenue Beam Therapeutics Corp (BEAM)|SRPT (Sarepta Therapeutics) - Revenue and Sales Volume|Company Total Revenue Twist Bioscience Corp TWST|Revenue and Sales Volume TXG|Revenue and Sales Volume intelliatx.com (NTLA)|Stoke Therapeutics - Company Sales|BioLife Solutions Inc (BLFS) - Company Total Revenue|wavelifesciences.com - Revenue and Sales Volume|Maze Therapeutics Corp (MAZE) - Company Sales|SION: Revenue and Sales Volume|Company Sales Volume PRME|Company Revenue Taysha Gene Therapies|Company Sales Volume QURE (uniQure)|Company Revenue MeiraGTx (MGTX)|REGENXBIO Corp - Company Sales Volume|Company Revenue Solid Biosciences SLDB|OCGN - Company Sales|pacb.com - Revenue and Sales Volume|Benitec (BNTC) - Company Sales|DSGN: Revenue and Sales Volume|RCKT - Company Gross Revenue|FDMT: Company Gross Revenue|Company Sales Volume LXEO (lexeotx.com)|Company Revenue Korro Bio Inc. (KRRO)|Company Total Sales EDIT|Revenue and Sales Volume SLN (Silence Therapeutics PLC)|Company Sales Revenue PRQR|CDXS - Company Revenue|nautilus.bio - Company Total Sales|Metagenomi, Inc (MGX) - Company Revenue|Company Sales Volume DTIL|Company Revenue Generation Bio|Revenue and Sales Volume Boundless Bio Inc|Company Revenue Exicure Corp (XCUR)|Company Gross Revenue Imunon|Revenue and Sales Volume PHIO (phiopharma.com)|Company Total Sales Volume mustangbio.com|RNAZ - Company Revenue|Company Total Revenue Bionano Genomics|APDN: Revenue and Sales Volume|Company Sales Volume BLUE|Company Sales IPA|OMGA: Company Sales Revenue|Revenue and Sales Volume OMIC|Company Gross Revenue Regulus Therapeutics|Company Revenue Syros SYRS|Company Sales Revenue TBIO|TCON: Company Sales|Unity Biotechnology, Inc. (UBX) - Company Sales